94 related articles for article (PubMed ID: 12764759)
1. Prospective evaluation in children of a new medical device intended to insure the correct administration of intrathecal antineoplastic agents.
Lecomte A; Thomaré P; Courant M; Suarez A; Méchinaud F
Med Pediatr Oncol; 2003 Jul; 41(1):89-90. PubMed ID: 12764759
[No Abstract] [Full Text] [Related]
2. Effectiveness of intrathecal rituximab in patients with acute lymphoblastic leukaemia relapsed to the CNS and resistant to conventional therapy.
Jaime-Pérez JC; Rodríguez-Romo LN; González-Llano O; Chapa-Rodríguez A; Gómez-Almaguer D
Br J Haematol; 2009 Mar; 144(5):794-5. PubMed ID: 19036096
[No Abstract] [Full Text] [Related]
3. Lumbar spinal fluid collections in children treated with intrathecal chemotherapy: elevated CSF protein as a diagnostic clue.
Almanjomi F; Armstrong D; Abla O; Naqvi A; Weitzman S; Hitzler J
Pediatr Blood Cancer; 2008 Aug; 51(2):295-8. PubMed ID: 18454469
[TBL] [Abstract][Full Text] [Related]
4. [Leukoencephalopathy after the intrathecal administration of cytostatics in acute lymphatic leukemia].
Hoelzer D
Dtsch Med Wochenschr; 1994 Nov; 119(47):1637. PubMed ID: 7982375
[No Abstract] [Full Text] [Related]
5. New technique for the intrathecal administration of chemotherapeutic agents.
Révész T; Bierings M; Rademaker C
Med Pediatr Oncol; 2000 Jan; 34(1):72-3. PubMed ID: 10611594
[No Abstract] [Full Text] [Related]
6. The lumbar puncture in pediatric oncology.
Coccia P; Ruggiero A; Attinà G; Lazzareschi I; Maurizi P; Riccardi R
Pediatr Med Chir; 2006; 28(4-6):73-8. PubMed ID: 17533900
[TBL] [Abstract][Full Text] [Related]
7. Treatment of pediatric acute lymphoblastic leukemia.
Tucci F; Aricò M
Haematologica; 2008 Aug; 93(8):1124-8. PubMed ID: 18669975
[No Abstract] [Full Text] [Related]
8. Intraspinal and intracranial hemorrhage after lumbar puncture.
Lee AC; Lau Y; Li CH; Wong YC; Chiang AK
Pediatr Blood Cancer; 2007 Feb; 48(2):233-7. PubMed ID: 16155928
[TBL] [Abstract][Full Text] [Related]
9. Osteonecrosis in children with acute lymphoblastic leukemia: a 10-year study from northern Greece.
Tragiannidis A; Athanassiadou F; Papageorgiou T; Petsatodis G; Sidi V; Koliouskas D
Pediatr Blood Cancer; 2007 Oct; 49(5):764. PubMed ID: 17216599
[No Abstract] [Full Text] [Related]
10. Bone mass and bone mineral metabolism at diagnosis and after intensive treatment in children with acute lymphoblastic leukemia.
Swiatkiewicz V; Wysocki M; Odrowaz-Sypniewska G; Koltan A; Manysiak S; Dylewska K
Med Pediatr Oncol; 2003 Dec; 41(6):578-80. PubMed ID: 14595724
[No Abstract] [Full Text] [Related]
11. Acute ascending motoric paraplegia following intrathecal chemotherapy for treatment of acute lymphoblastic leukemia in children: case reports and review of the literature.
Rolf N; Boehm H; Kaindl AM; Lauterbach I; Suttorp M
Klin Padiatr; 2006; 218(6):350-4. PubMed ID: 17080338
[TBL] [Abstract][Full Text] [Related]
12. Low bone mineral density in childhood acute lymphoblastic leukemia.
Naithani R; Desai A
Indian Pediatr; 2009 Jun; 46(6):542-3; author reply 543-4. PubMed ID: 19556673
[No Abstract] [Full Text] [Related]
13. Prospective evaluation of clinical and laboratory effects of intrathecal chemotherapy on children with acute leukemia.
Keidan I; Bielorei B; Berkenstadt H; Aizenkraft A; Harel R; Huna-Baron R; Kaplinsky C
J Pediatr Hematol Oncol; 2005 Jun; 27(6):307-10. PubMed ID: 15956882
[TBL] [Abstract][Full Text] [Related]
14. Pediatric oncology sedation trial (POST): A double-blind randomized study.
Nagel K; Willan AR; Lappan J; Korz L; Buckley N; Barr RD
Pediatr Blood Cancer; 2008 Nov; 51(5):634-8. PubMed ID: 18649369
[TBL] [Abstract][Full Text] [Related]
15. [Late effects after treatment of childhood leukemia. The Danish Society of Pediatrics].
Nysom K
Ugeskr Laeger; 2002 Mar; 164(12):1651. PubMed ID: 11924274
[No Abstract] [Full Text] [Related]
16. Transverse myelopathy following intrathecal administration of chemotherapy.
Teh HS; Fadilah SA; Leong CF
Singapore Med J; 2007 Feb; 48(2):e46-9. PubMed ID: 17304378
[TBL] [Abstract][Full Text] [Related]
17. Long-term results of a randomized trial on extended use of high dose L-asparaginase for standard risk childhood acute lymphoblastic leukemia.
Pession A; Valsecchi MG; Masera G; Kamps WA; Magyarosy E; Rizzari C; van Wering ER; Lo Nigro L; van der Does A; Locatelli F; Basso G; Aricò M
J Clin Oncol; 2005 Oct; 23(28):7161-7. PubMed ID: 16192600
[TBL] [Abstract][Full Text] [Related]
18. Octreotide therapy in asparaginase-associated pancreatitis in childhood acute lymphoblastic leukemia.
Wu SF; Chen AC; Peng CT; Wu KH
Pediatr Blood Cancer; 2008 Dec; 51(6):824-5. PubMed ID: 18726919
[TBL] [Abstract][Full Text] [Related]
19. Biology and treatment of acute lymphoblastic leukemia.
Pieters R; Carroll WL
Pediatr Clin North Am; 2008 Feb; 55(1):1-20, ix. PubMed ID: 18242313
[TBL] [Abstract][Full Text] [Related]
20. Almost normal cognitive function in patients during therapy for childhood acute lymphoblastic leukemia without cranial irradiation according to ALL-BFM 95 and COALL 06-97 protocols: results of an Austrian-German multicenter longitudinal study and implications for follow-up.
Krappmann P; Paulides M; Stöhr W; Ittner E; Plattig B; Nickel P; Lackner H; Schrappe M; Janka G; Beck JD; Langer T
Pediatr Hematol Oncol; 2007 Mar; 24(2):101-9. PubMed ID: 17454775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
